Metraipolis › archive › dc_2ccf73eafc21
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41868651
- DOI
- 10.3389/falgy.2026.1766647
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T02:21:39.977Z
- SHA-256 of the archived text
72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a- Stable URL of this page
https://metraipolis.com/documento/dc_2ccf73eafc21
How to cite
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651 — Europe PMC (en), https://europepmc.org/article/MED/41868651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ccf73eafc21 (Metraipolis archive dc_2ccf73eafc21, sha256 72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a)
BibTeX
@misc{dc2ccf73eafc21,
title = {Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis — Europe PMC PMID:41868651},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41868651},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ccf73eafc21; sha256 72d364f235074666b1856ce76a19d487862eef901cdbbb9599ec3b86afac433a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41868651. Agents can read the archived copy with the MCP tool read_document.